Clinical trial Recruiting at 1 site Observational Ages 13 to 35

Exploring brain structure and gene expression in mental disorders

Official title: Psychiatric Multi-omics and Neuroimaging Project Database

Run by Second Xiangya Hospital of Central South University · NCT06580860 · Data updated 2026-11-12

This study looks at how brain structure and genes relate to schizophrenia and other mental disorders in young people to better understand these conditions.

Quick facts

Study typeObservational
Ages13 Years to 35 Years
SexAll
Enrollment1899 (estimated)
SponsorSecond Xiangya Hospital of Central South University
Academic / other
Locations1 site (Changsha, Hunan)
StatusRecruiting
StartedJanuary 2016
Main results expectedJanuary 2027
Study endsJanuary 2027
Registry record updatedMarch 13, 2026
Trial IDNCT06580860 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 13-35 with a diagnosis of schizophrenia or other specified mental disorders who have been ill for less than 24 months.

Probably not a fit

Patients with a family history of psychotic disorders or those with significant physical or neurological diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the relationship between brain structure, function, and gene expression in patients with schizophrenia and other mental disorders. Participants aged 13-35 will undergo baseline and follow-up assessments while adhering to their prescribed medications for one year. The goal is to identify biological markers and understand how gene-environment interactions affect brain networks, which could enhance the understanding of schizophrenia's neuropathological basis.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic and treatment strategies for schizophrenia and related mental disorders.

How similar studies have gone: While there have been studies exploring similar biological markers in mental disorders, this specific multi-omics approach combined with neuroimaging is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age: 13-35 years old(Patients with healthy siblings can be extended to 14-35 years of age)
* Course of disease: \<24 months
* Priority is given to patients who have never taken medicine or duration of drug use \< 2 weeks
* No nuclear magnetic contraindications.

Exclusion Criteria:

* Family history of psychotic disorders, history of psychoactive substances abuse, alcohol dependence, or nicotine dependence
* Have a major physical disease or infectious disease
* History of coma and serious neurological disease 4.MRI contraindications.

Where it's running

  • The Second Xiangya hospital of central south univerity
    Changsha, Hunan, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.